Company Filing History:
4 out of 1,735 
1 out of 1 
1 out of 9 Years Active: 2012-2017
Title: Gerben Meile Zijlstra: Innovator in Cell Culturing Processes
Introduction
Gerben Meile Zijlstra is a distinguished inventor based in Groningen, Netherlands, with a notable portfolio of six patents. His work primarily focuses on novel processes in the biotechnological field, particularly in cell culturing. This article explores his latest patents, career highlights, and collaborative efforts.
Latest Patents
Gerben Zijlstra's recent innovations include cutting-edge methods for culturing cells, specifically E1-immortalized HER cells, with a special emphasis on PER.C6 cells. His patented processes involve cultivating these cells in a reactor within a suspension of a cell culture medium. This method allows for the efficient production of biological substances, notably antibodies. The processes include a unique separation system that effectively isolates the biological substance from lower molecular weight components, ensuring a high yield of desired products while continuously removing unnecessary substances from the cell culture.
Career Highlights
Throughout his career, Gerben Zijlstra has garnered experience at several reputed companies. He has worked at DSM IP Assets B.V. and Patheon Holdings B.V., where he has contributed to advancements in bioprocessing technologies. His extensive knowledge and research have positioned him as a respected figure in the field of cell culturing and biotechnology.
Collaborations
Gerben has collaborated with prominent professionals, including Jacob Schilder and Robert Patrick Hoff. These partnerships have led to significant advancements and innovations in their respective fields, further enhancing the biotechnological landscape.
Conclusion
Gerben Meile Zijlstra’s contributions to the field of biotechnology, particularly in the culturing of cells, have had a substantial impact on the industry. His patented processes showcase his innovative mindset and dedication to advancing scientific knowledge, making him a significant figure in the realm of biotechnological inventions. As he continues to explore new frontiers, the implications of his work hold great potential for the future of cell culture and biopharmaceutical production.